MoneyWorks4Me

The revenue zoomed 13.08% to Rs. 8367.60 millions for the quarter ended September 2023 as compared to Rs. 7399.60 millions during the corresponding quarter last year.The company has announced a 48.40% increase in its profits to Rs . 1450.20  millions for the  quarter ended September 2023 compared to Rs. 977.20 millions in the corresponding quarter in the previous year.Operating profit for the quarter ended September 2023 rose to 2416.80 millions as compared to 1675.10 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 8367.60 7399.60 13.08 16893.40 14560.90 16.02 28841.60 21898.80 31.70
Other Income 68.40 17.20 297.67 119.70 22.30 436.77 86.50 386.10 -77.60
PBIDT 2416.80 1675.10 44.28 4816.40 3360.00 43.35 6733.40 5475.20 22.98
Interest 94.60 76.00 24.47 206.70 133.90 54.37 343.10 49.50 593.13
PBDT 2322.20 1599.10 45.22 4609.70 3226.10 42.89 6390.30 5425.70 17.78
Depreciation 315.00 277.10 13.68 621.50 534.00 16.39 1119.90 712.80 57.11
PBT 2007.20 1322.00 51.83 3988.20 2692.10 48.14 5270.40 4712.90 11.83
TAX 557.00 344.80 61.54 1092.30 702.00 55.60 1381.50 1102.90 25.26
Deferred Tax 132.70 111.30 19.23 265.70 228.50 16.28 548.00 -122.10 -548.81
PAT 1450.20 977.20 48.40 2895.90 1990.10 45.52 3888.90 3610.00 7.73
Equity 155.00 154.70 0.19 155.00 154.70 0.19 154.80 154.60 0.13
PBIDTM(%) 28.88 22.64 27.59 28.51 23.08 23.55 23.35 25.00 -6.62
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..